Mind Medicine Inc (NAS:MNMD)
$ 8.19 -0.78 (-8.7%) Market Cap: 600.59 Mil Enterprise Value: 438.17 Mil PE Ratio: 0 PB Ratio: 2.93 GF Score: 41/100

Q4 2022 Mind Medicine (MindMed) Inc Earnings Call Transcript

Mar 09, 2023 / 09:30PM GMT
Release Date Price: $3.18 (-4.79%)
Operator

Good afternoon, and welcome to the Mind Medicine fourth quarter and full-year 2022 financial results and corporate update conference call. (Operator Instructions) This call is being webcast live on the investors and media section of MindMed's website at mindmed.co, and the recording will be available after the call.

For opening remarks, I would like to introduce Rob Barrow, CEO of MindMed. Please go ahead.

Rob Barrow;MindMed;Inc.;CEO;Director
Mind Medicine

()-&

Thank you, and good afternoon, everyone. Welcome to our fourth quarter and full-year 2022 financial results and corporate update conference call. The press release reporting our financial results is available in the investors and media section of MindMed's website, and our annual report on Form 10-K for the year ended December 31, 2022, will be filed today with the Securities and Exchange Commission.

Joining me today is Schond Greenway, our CFO; Dr. Dan Karlin, our Chief Medical Officer; and Dr. Miri Halperin Wernli,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot